Essential Biotech Portfolio

The Essential Biotech Portfolio from Pall Life Sciences provides a complete and optimized capability for the development and processing of monoclonal antibodies (mAbs) uniquely covering all key applications from Cell Culture through to the formulation and filling space. Working with the Essential Biotech Portfolio can make the development and processing of mAbs, Easier, Faster and Better.

Please click on a room in the ‘Essential Biotech Facility’ to discover our integrated technology solutions offering and specific solutions for mAbs
QC Analytics Media & Buffer Preparation Culture cellulaire élimination de cellules Capture & Viral Inactivation Purification & Polishing Virus Filtration & Product Concentration Compounding remplissage final Process Development Area